title: Confronting parasites from Canada.
authors.forename: Terry W
authors.initials: TW
authors.lastname: Spithill
authors.forename: Kris
authors.initials: K
authors.lastname: Chadee
authors.forename: Armando P
authors.initials: AP
authors.lastname: Jardim
authors.forename: Roger K
authors.initials: RK
authors.lastname: Prichard
authors.forename: Paula
authors.initials: P
authors.lastname: Ribeiro
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D002170:Canada; D004351:Drug Resistance; D004748:Entamoeba histolytica / Q000276:immunology / Q000378:metabolism; D005210:Fasciola hepatica / Q000276:immunology; D005786:Gene Expression Regulation; D006373:Helminthiasis / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007378:Interleukins / Q000145:classification / Q000276:immunology; D007891:Leishmania / Q000166:cytology / Q000302:isolation & purification; D008830:Microbodies / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D010271:Parasites / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity*; D010272:Parasitic Diseases / Q000188:drug therapy / Q000469:parasitology*
chemical_list: D000871:Anthelmintics; D007378:Interleukins; D018377:Neurotransmitter Agents